{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:38:04Z","timestamp":1780475884770,"version":"3.54.1"},"reference-count":34,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"unspecified","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ferring Pharmaceuticals (Shanghai) Company","award":["20191727"],"award-info":[{"award-number":["20191727"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,9,22]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Uterine contractions may interfere with embryo implantation in assisted reproductive technology. To reduce these contractions and improve success rates, the oxytocin antagonist atosiban has been suggested for administration during embryo transfer. The aim of this study is to evaluate the effectiveness of atosiban in increasing live birth rates among women who have previously experienced a single implantation failure and are scheduled for single blastocyst transfer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We conduct a single-centre randomised controlled study comparing atosiban and placebo in women undergoing a single blastocyst transfer with a previous failed blastocyst transfer. Women with endocrine or systemic illnesses, recurrent miscarriages, uterine malformations or fibroids, untreated hydrosalpinx, endometriosis (stage III or IV) or uterine fibroids, as well as women undergoing preimplantation genetic testing, are ineligible. The primary outcome is live birth resulting from the frozen-thawed embryo transfer. Secondary outcomes include biochemical\/clinical pregnancy, miscarriage, ectopic pregnancy, multiple pregnancies as well as maternal and perinatal outcomes. We plan to recruit 1100\u2009women (550\u2009women per group). This will allow us to demonstrate or refute an increase in live birth rate from 40% to 50%. Data analysis will follow the intention-to-treat principle. We will measure patterns of uterine peristalsis which will allow subgroup analysis for women with or without uterine peristalsis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study has been approved by the Institutional Review Board of Northwest Women\u2019s and Children\u2019s Hospital (No. SZ2019001). Written informed consent will be obtained from each participant before randomisation. The results of the trial will be presented at scientific meetings and reported in publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ChiCTR1900022333.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-076390","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T13:11:06Z","timestamp":1697461866000},"page":"e076390","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: study protocol for a randomised controlled trial"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0890-8913","authenticated-orcid":false,"given":"He","family":"Cai","sequence":"first","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"},{"name":"Guangzhou Kapok Medical Group, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlin","family":"Xie","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-0909","authenticated-orcid":false,"given":"Wentao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8337-550X","authenticated-orcid":false,"given":"Ben W","family":"Mol","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Monash Medical Centre, Clayton, Victoria, Australia"},{"name":"Aberdeen Centre for Women\u2019s Health Research, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7643-4124","authenticated-orcid":false,"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[{"name":"The Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"},{"name":"Translational Medicine Center, Northwest Women\u2019s and Children\u2019s Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"2025121402450066000_13.10.e076390.1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey242"},{"key":"2025121402450066000_13.10.e076390.2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/humupd\/dmac009","article-title":"Interventions to optimize embryo transfer in women undergoing assisted conception: a comprehensive systematic review and meta-analyses","volume":"28","author":"Tyler","year":"2022","journal-title":"Hum Reprod Update"},{"key":"2025121402450066000_13.10.e076390.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00132-0"},{"key":"2025121402450066000_13.10.e076390.4","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu058"},{"key":"2025121402450066000_13.10.e076390.5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq222"},{"key":"2025121402450066000_13.10.e076390.6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702996"},{"key":"2025121402450066000_13.10.e076390.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.2.385"},{"key":"2025121402450066000_13.10.e076390.8","doi-asserted-by":"publisher","DOI":"10.1093\/molehr\/gah039"},{"key":"2025121402450066000_13.10.e076390.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2004.00049.x"},{"key":"2025121402450066000_13.10.e076390.10","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/350546","article-title":"The oxytocin-oxytocin receptor system and its antagonists as Tocolytic agents","volume":"2011","author":"Vrachnis","year":"2011","journal-title":"Int J Endocrinol"},{"key":"2025121402450066000_13.10.e076390.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.04.009"},{"key":"2025121402450066000_13.10.e076390.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.07.386","article-title":"A randomized double blind comparison of Atosiban in Unselected patients undergoing in vitro fertilization treatment","volume":"102","author":"Ng","year":"2014","journal-title":"Fertility and Sterility"},{"key":"2025121402450066000_13.10.e076390.13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejogrb.2021.08.017","article-title":"Effects of Atosiban on uterine Peristalsis following frozen embryo transfer: A randomized controlled trial","volume":"265","author":"Buddhabunyakan","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025121402450066000_13.10.e076390.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2012.05.014"},{"key":"2025121402450066000_13.10.e076390.15","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/09513590.2016.1180680","article-title":"Application of Atosiban in frozen-thawed cycle patients with different times of embryo transfers","volume":"32","author":"He","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2025121402450066000_13.10.e076390.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(00)70351-6"},{"key":"2025121402450066000_13.10.e076390.17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90365-8"},{"key":"2025121402450066000_13.10.e076390.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00501-9"},{"key":"2025121402450066000_13.10.e076390.19","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/humrep\/deaa241","article-title":"Core outcome measure for infertility trials (COMMIT) initiative. developing a core outcome set for future infertility research: an international consensus development study","volume":"35","author":"Duffy","year":"2020","journal-title":"Hum Reprod"},{"key":"2025121402450066000_13.10.e076390.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175501","article-title":"The impact of Atosiban on pregnancy outcomes in women undergoing in vitro fertilization-embryo transfer: A meta-analysis","volume":"12","author":"Huang","year":"2017","journal-title":"PLoS One"},{"key":"2025121402450066000_13.10.e076390.21","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.7.1968"},{"key":"2025121402450066000_13.10.e076390.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)00518-5"},{"key":"2025121402450066000_13.10.e076390.23","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1177\/1933719119831791","article-title":"The effect of Atosiban on patients with difficult embryo transfers undergoing in vitro fertilization\u2013embryo transfer","volume":"26","author":"Yuan","year":"2019","journal-title":"Reprod Sci"},{"key":"2025121402450066000_13.10.e076390.24","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.95834"},{"key":"2025121402450066000_13.10.e076390.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.09.015"},{"key":"2025121402450066000_13.10.e076390.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)00179-1"},{"key":"2025121402450066000_13.10.e076390.27","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des257"},{"key":"2025121402450066000_13.10.e076390.28","first-page":"227","article-title":"The role of oxytocin antagonists in repeated implantation -Failure","volume":"4","author":"Decleer","year":"2012","journal-title":"Facts Views Vis Obgyn"},{"key":"2025121402450066000_13.10.e076390.29","article-title":"Oxytocin antagonists for assisted reproduction","volume":"9","author":"Craciunas","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121402450066000_13.10.e076390.30","doi-asserted-by":"crossref","DOI":"10.1186\/s12958-022-00999-y","article-title":"A randomized double blind comparison of Atosiban in patients with recurrent implantation failure undergoing IVF treatment","volume":"20","author":"Tang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"2025121402450066000_13.10.e076390.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6123(02)39030-7"},{"key":"2025121402450066000_13.10.e076390.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.08.089"},{"key":"2025121402450066000_13.10.e076390.33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.fertnstert.2006.09.017","article-title":"Oxytocin antagonists may improve infertility treatment","volume":"88","author":"Pierzynski","year":"2007","journal-title":"Fertil Steril"},{"key":"2025121402450066000_13.10.e076390.34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/humrep\/deaa369","article-title":"Effect of the oxytocin receptor antagonist Nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials","volume":"36","author":"Griesinger","year":"2021","journal-title":"Hum Reprod"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-076390","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T10:45:09Z","timestamp":1765709109000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-076390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":34,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,16]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-076390"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-076390","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}